Cell Free Circulating Nucleic Acids as New Tumor Diagnostics From Human Plasma Samples.
NCT04081194 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2019-09-17
Summary
Cell Free Circulating Nucleic Acids as New Tumor Diagnostics From Human Plasma Samples.
Conditions
- New Tumor Diagnostics From Human Plasma Samples
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Hesham A Abdel-Baset, Prof. · Assiut University- Faculty of Medicine- Clinical Pathology dept.
Eligibility
- Min Age
- 50 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-10-01
- Primary Completion
- 2019-11-01
- Completion
- 2019-12-01
Countries
- Egypt
Study Locations
More Related Trials
-
Circulating Tumor DNA Exposure in Peripheral Blood
NCT03517332 ·Status: UNKNOWN
-
ctDNA in Patients With Thyroid Nodules
NCT02778412 ·Status: TERMINATED
-
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs
NCT05782985 ·Status: UNKNOWN
-
Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients
NCT05343832 ·Status: UNKNOWN
-
Toluidine Blue Versus Frozen Sections for Assessment of Tumor Margins in Oral Squamous Cell Carcinoma
NCT03554967 ·Status: COMPLETED
-
Cancer in Infants: South Egypt Cancer Institute Experience
NCT02668354 ·Status: UNKNOWN
-
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing
NCT04213326 ·Status: COMPLETED
-
Detection of Plasma Circulating Tumor DNA in Gastric Cancer
NCT05027347 ·Status: UNKNOWN
-
Salivary LINC00657 as a Diagnostic Biomarker for Oral Squamous Cell Carcinoma
NCT05821179 ·Status: COMPLETED
-
IDENTIFY Study: Natural History of Maternal Neoplasia
NCT04049604 ·Status: RECRUITING ·Phase: NA
-
The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study
NCT04957901 ·Status: RECRUITING
-
Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer
NCT05513144 ·Status: UNKNOWN
-
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
NCT05685524 ·Status: UNKNOWN
-
Liquid Biopsy of Head and Neck Cancer Patients in Blood and Saliva
NCT05122507 ·Status: UNKNOWN
-
Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA
NCT04104633 ·Status: COMPLETED ·Phase: NA
-
Detection of Tumor DNA in Blood Samples From Cancer Patients
NCT02288754 ·Status: UNKNOWN
-
Tissue Acquisition for Molecular Diagnostics
NCT00001580 ·Status: COMPLETED
-
Cancer Survivorship in Hematologic Malignancies
NCT05780411 ·Status: UNKNOWN
-
Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCC
NCT03302325 ·Status: COMPLETED
-
Blood Cell RNA-Based Cancer Detection
NCT05839834 ·Status: RECRUITING
-
Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)
NCT02443948 ·Status: UNKNOWN
-
Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
NCT06148298 ·Status: RECRUITING
-
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
NCT04354064 ·Status: RECRUITING
-
Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability
NCT05853198 ·Status: RECRUITING ·Phase: NA
-
Lumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell Lung Cancer
NCT06816979 ·Status: NOT_YET_RECRUITING ·Phase: NA